Recent research also points out that, for HCC patients, the peritumoral monocytes will likely enhance the aerobic glycolytic level, while the aerobic glycolysis can thereby elicit the PD-L1 level via the PFKFB3-NF-κB pathway (Chen et al., 2019). The gene discussed is PFKFB3; the disease is hepatocellular carcinoma.